Catherine Ramsey
Stock Analyst at Baird
(2.20)
# 2,914
Out of 4,944 analysts
51
Total ratings
30.77%
Success rate
2.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ILMN Illumina | Maintains: Neutral | $84 → $105 | $101.11 | +3.85% | 6 | Jul 28, 2025 | |
WAT Waters | Maintains: Outperform | $374 → $352 | $296.83 | +18.59% | 11 | Jul 16, 2025 | |
TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $28.65 | +53.58% | 7 | May 6, 2025 | |
RVTY Revvity | Maintains: Outperform | $127 → $125 | $90.93 | +37.47% | 5 | Apr 29, 2025 | |
NTRA Natera | Maintains: Outperform | $183 → $188 | $157.70 | +19.21% | 6 | Feb 28, 2025 | |
CSTL Castle Biosciences | Maintains: Outperform | $36 → $37 | $19.41 | +90.62% | 8 | Feb 28, 2025 | |
TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $484.79 | +37.17% | 2 | Nov 1, 2022 | |
A Agilent Technologies | Maintains: Outperform | $155 → $160 | $120.29 | +33.01% | 5 | Aug 17, 2022 | |
EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $44.91 | +67.00% | 1 | Aug 3, 2022 |
Illumina
Jul 28, 2025
Maintains: Neutral
Price Target: $84 → $105
Current: $101.11
Upside: +3.85%
Waters
Jul 16, 2025
Maintains: Outperform
Price Target: $374 → $352
Current: $296.83
Upside: +18.59%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $28.65
Upside: +53.58%
Revvity
Apr 29, 2025
Maintains: Outperform
Price Target: $127 → $125
Current: $90.93
Upside: +37.47%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $157.70
Upside: +19.21%
Castle Biosciences
Feb 28, 2025
Maintains: Outperform
Price Target: $36 → $37
Current: $19.41
Upside: +90.62%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $484.79
Upside: +37.17%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $120.29
Upside: +33.01%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $44.91
Upside: +67.00%